Showing results (91-100 of 104) with videos related to
Sort By:
Pageof 11
Blood|April 1, 1996
CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's diseaseD A Filippa, M Ladanyi, N Wollner, et al.Annals of Plastic Surgery|August 1, 1989
Selection of optimal axon ratio for nerve regenerationS E Mackinnon, A L Dellon, J P O'Brien, et al.The Journal of Bone and Joint Surgery. British Volume|March 1, 1987
The rib deformity in adolescent idiopathic scoliosis. A prospective study to evaluate changes after Harrington distraction and posterior fusionC R Weatherley, V Draycott, J F O'Brien, et al.Proceedings of the National Academy of Sciences of the United States of America|January 1, 1989
Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sitesC Cordon-Cardo, J P O'Brien, D Casals, et al.Cancer|November 15, 1994
A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistanceL Saltz, B Murphy, N Kemeny, et al.European Journal of Physical and Rehabilitation Medicine|March 14, 2014
Actual evidence in the medical approach to adolescents with idiopathic scoliosisS Negrini, J C De Mauroy, T B Grivas, et al.Journal of Cellular Biochemistry|October 1, 1988
Increased epidermal growth factor receptor in multidrug-resistant human neuroblastoma cellsM B Meyers, W P Shen, B A Spengler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's diseaseJ Yahalom, S C Gulati, M Toia, et al.The Journal of Pathology|July 13, 2002
Nerve growth factor expression and innervation of the painful intervertebral discA J Freemont, A Watkins, C Le Maitre, et al.Leukemia & Lymphoma|September 7, 2000
Granulocyte-colony stimulating factor (G-CSF) may improve disease outcome in elderly patients with diffuse large cell lymphoma (DLCL) treated with CHOP chemotherapyG B Donnelly, J Glassman, C Long, et al.Pageof 11